Fact CheckerSign in

NCT07209982Completed

Dual Task Training Versus Single Task Training in Chronic Hemiplegic Stroke Patients

Source: ClinicalTrials.gov · Last updated 7 Oct 2025

Brief summary (registry, in English)

What is this study about? This study compares two common ways of practicing walking and balance after a stroke: (1) dual-task training, where a person walks or balances while doing a second task (such as counting backward or carrying a light object), and (2) single-task training, where a person practices walking and balance without any extra task. The goal is to learn whether practicing with or without an added task is more practical and acceptable for people living with long-standing weakness on one side of the body (hemiplegia) after stroke. Why is this important? Many everyday activities-walking while talking, looking for a bus, or carrying a bag-require attention to more than one thing at a time. Some stroke survivors find this difficult. Training that safely mimics real-life multitasking may help therapists design better rehabilitation plans. Who can take part? Adults aged 45-65 years with a diagnosis of hemiplegic stroke who can walk without hands-on help may be eligible. People with other neurological conditions that affect walking, severe problems with understanding or communication, or recent serious medical/surgical issues will not be included. Additional screening will check safety for exercise. What will happen if I join? Participants are randomly assigned (like a coin toss) to one of two groups: Dual-task training group: walking/balance activities plus a simple cognitive or motor task. Single-task training group: the same walking/balance activities without any extra task. Both groups attend 60-minute sessions, three times per week, for six weeks at The University of Lahore Teaching Hospital or Sehat Medical Complex. A trained therapist supervises all sessions and adjusts difficulty gradually. Short rest breaks are provided. What will be measured? At baseline, 2 weeks, 4 weeks, and 6 weeks, an assessor who does not know the assigned group will record walking and balance using the Tinetti Performance-Oriented Mobility Assessment (POMA). Safety (such as any falls, dizziness, or discomfort) and attendance will also be recorded. What are the possible risks and benefits? Risks are similar to supervised physiotherapy: temporary muscle soreness, fatigue, or loss of balance. Therapists use safety measures (close supervision, stable equipment, and rest periods). Participants may experience the general benefits of structured rehabilitation (practice, education, and monitored activity). Taking part is voluntary, and usual care remains available. Privacy and cost Personal information is kept confidential and stored securely. There is no payment for participation. There are no charges for study-related therapy sessions. Time commitment About 18 sessions over 6 weeks, plus four short assessment visits. Contacts Study team members can answer questions at any time and will obtain written informed consent before any study procedures begin.

Status (registry)
Completed
Study type
Interventional
Enrollment
62 (actual)
First submitted
29 Sept 2025
Start date
15 Jan 2025
Primary completion date
19 Aug 2025
Lead sponsor
University of Lahore
Diseases
Stroke
NCT number
NCT07209982

What you commit to

  • Study type: Interventional
  • Participants enrolled: 62
  • From 15 Jan 2025 to the primary completion date, 19 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of other neurological conditions effecting mobility (Muzio et al., 2023).
  • Recent acute medical/surgical conditions unrelated to stroke.(Nam, 2023)
  • Other Systemic disease

Other

  • Severe cognitive impairments or communication difficulties. (Liu et al., 2017)
  • Participants with severe hemiparesis who are unable to produce movement accurately (Zhang et al., 2022).

Who the study is looking for

  • Patients diagnosed with hemiplegic stroke (Nam, 2023)
  • Both males and females patients
  • Participants ≤ 6 months poststroke (Nam, 2023)
  • Participants age between 45-65(Zhou et al., 2021)
  • Patients who are able to walk without assistance.(Joya, 2023) .

Age in the registry: 45 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The University of Lahore Teaching Hospital
Coordinator of this site? Confirm its status
LahorePakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.